Depakote (Divalproex): Patient Information for Australia
1. Basic Product Information
| International Non-proprietary Name (INN): | Divalproex sodium (also known as Divalproex, Valproic acid derivatives) |
| Australia Brand Names: | Epilim, Epilim Chrono, Valpro, Valproate Sandoz, Valprease (Depakote brand itself may not be listed in the PBS; check with your pharmacist for equivalent generics and brands.) |
| Anatomical Therapeutic Chemical (ATC) Code: | N03AG01 (Valproic acid and derivatives) |
| Available Forms and Strengths: | Tablets (enteric coated, modified release), syrup, oral liquid, crushable tablets Common strengths: 200 mg, 300 mg, 500 mg, 600 mg (tablets); 200 mg/5 mL, 250 mg/5 mL (liquid) |
| Manufacturers (Australia): | Sanofi-Aventis, Sandoz, Alphapharm, Apotex |
| Prescription Status: | Prescription only medicine (Schedule 4, S4) in Australia. |
2. Mechanism of Action
- For patients: Divalproex helps balance the natural chemicals in your brain, especially those linked to seizures or mood changes. It works mainly by increasing a substance called GABA, which helps calm brain activity.
- For healthcare professionals: Divalproex (ionised to valproate) increases brain GABA levels via inhibition of GABA transaminase and succinic semialdehyde dehydrogenase, reduces neuronal firing through attenuation of voltage-gated sodium and T-type calcium channels, and affects histone deacetylase activity.
3. Pharmacokinetics
- Absorption: Rapid and nearly complete gastrointestinal absorption. Modified-release forms increase time to peak.
- Time to Peak Concentration: 2 to 4 hours (standard tablet), 6 to 12 hours (modified/extended release)
- Distribution: Highly protein-bound (~90%; may decrease in some illnesses)
- Metabolism: Hepatic (liver), mainly via glucuronidation and mitochondrial β-oxidation
- Elimination: Mostly via urine (>80% within 72 hours)
- Half-life: Average 9–16 hours in adults; shorter in children
- Duration of Action: 12–24 hours (depending on formulation and dose frequency)
4. Use in Everyday Life and Best Practices
Divalproex is commonly prescribed for:
- Epilepsy (seizure control): Both adults and children
- Bipolar disorder: Especially for treating manic episodes and maintenance
- Migraine prevention: Especially for adults with frequent or severe migraines
Typical dose ranges:
- For epilepsy in adults: 600–2,400 mg daily, usually split into 1–2 doses
- For bipolar disorder: commonly 1,000–2,000 mg daily (higher doses rarely needed)
- For migraine prevention: 500–1,000 mg daily
- Always follow your doctor’s instructions. Never adjust your dose without advice.
In Australia, your prescription may specify a brand (e.g., Epilim, Sandoz Valproate) — but most brands contain the same active ingredient. Your pharmacist can advise if substitution is possible under the PBS (Pharmaceutical Benefits Scheme).
How to take:
- Swallow tablets whole, do not crush or chew unless specifically advised (for crushable tablets).
- Take the medicine at the same time(s) every day for best results.
- Do not stop suddenly without consulting your doctor – sudden withdrawal may cause seizures or mood relapse.
5. Dosing: Morning vs Evening
Depakote/divalproex can be taken in the morning, evening, or split between both, depending on:
- Formulation (extended vs standard release)
- Your doctor’s recommendation
- Personal tolerability
Advantages of evening dosing: Some side effects (like drowsiness) may be less bothersome if you take at bedtime.
Tips for regularity: Use an alarm, pillbox, or phone reminder. Consistency with timing helps control symptoms and blood levels.
6. Taking with Food or On an Empty Stomach
With or without food: Divalproex can be taken with or after meals to reduce stomach upset, which is a common early side effect. Food may slightly slow absorption, but does not affect the medicine’s overall effectiveness.
Australian dietary habits: If you usually eat a light breakfast, consider taking your medicine with your main meal (e.g., lunch or dinner). For children or people with nausea, pairing the dose with food (such as toast or fruit) can help.
7. Interaction Warnings
| Item | Interaction | Recommendation |
|---|---|---|
| Alcohol | Increases drowsiness, risk of liver problems, risk of seizures if dependent and alcohol is suddenly stopped | Avoid or limit alcohol intake |
| Other anticonvulsants (e.g., phenytoin, carbamazepine, lamotrigine) | Alter plasma drug levels; may increase risk of side effects or decrease effectiveness | Close monitoring and dose adjustments by your doctor |
| Warfarin & anticoagulants | Increased risk of bleeding (valproate affects blood clotting) | INR monitoring; inform clinic/pharmacy |
| Antibiotics (e.g., erythromycin) | Possible increased valproate levels | Notify your doctor if prescribed new antibiotics |
| St John’s Wort, herbal medicines | Unpredictable effects; may reduce valproate levels | Avoid unless approved by your healthcare professional |
| Food | No major interactions; food can reduce stomach upset | Prefer with food if stomach upset occurs |
8. Indications
| Indication | Official (TGA) | Off-label use |
|---|---|---|
| Epilepsy – various seizure types | ✔ | - |
| Bipolar disorder (mania, maintenance) | ✔ | - |
| Prevention of migraine headaches | ✔ | - |
| Agitation in dementia, neuropathic pain, borderline personality disorder | - | Sometimes |
| Schizophrenia augmentation, PTSD, tardive dyskinesia | - | Occasional, not standard |
9. Dosing According to Clinical Indication
| Indication | Adults | Paediatrics (Children & Adolescents) | Elderly |
|---|---|---|---|
| Epilepsy | Start 600 mg/day, up to 2,400 mg/day (divided doses) | 15–30 mg/kg/day, up to max 2,500 mg/day (divided doses) | Start lower & titrate slowly, consider 300–700 mg/day |
| Bipolar disorder | Initial: 1,000 mg/day (can titrate to 2,000 mg/day if needed) | Not routinely used (off-label in select cases) | Start low; monitor hepatic and cognitive function closely |
| Migraine prevention | 500–1,000 mg/day in divided doses | Rare; consult paediatric specialist | Low starting dose; titrate based on tolerance |
Note: Doses are indicative; your doctor may personalise according to your needs, age, and condition.
10. Safety Profile and Side Effects
| Side Effect | Frequency | Notes/Cautions |
|---|---|---|
| Nausea, stomach upset, diarrhoea | Common | Often mild, improves if taken with food |
| Sleepiness, drowsiness, tiredness | Common | May decrease after first weeks |
| Weight gain, increased appetite | Common | Watch diet & activity; discuss with dietitian if problematic |
| Hair thinning/loss | Uncommon | Reversible on stopping; dietary zinc/selenium may help |
| Tremor (shaky hands) | Occasional | If troublesome, inform your doctor |
| Liver function changes, hepatitis | Rare but serious | Liver tests required regularly; highest risk in first 6 months |
| Blood cell changes (bruising, bleeding) | Rare | Regular blood checks; tell doctor about unusual bleeding |
| Allergic skin reactions, rash | Rare | Report any rash, swelling, difficulty breathing urgently |
| Birth defects/foetal harm (pregnancy) | High risk | Not recommended in pregnancy or for women trying to conceive; strict contraceptive measures & specialist advice required |
11. Guidelines for Proper Use (Australia)
- Always carry your Medicare card and medical information in case of emergencies.
- If you miss a dose, take it as soon as you remember unless it is almost time for the next – then skip and do not double up.
- Regular blood tests are essential (liver function, full blood count, valproate levels), especially in the first 6–12 months.
- For women and girls of childbearing potential, a Pregnancy Prevention Programme is in place—consult your doctor about safe contraception and regular reviews.
- Alert your pharmacist or specialist if you are starting any new medication, supplements, or herbal remedies.
- If travelling interstate or overseas, carry an updated list of your medications and check airline/carrier regulations for carrying pharmacy medicines.
- Store Depakote/divalproex at room temperature and out of reach of children.
12. Alternative Treatment Options (PBS, Comparative Overview)
- Epilepsy: Carbamazepine, Lamotrigine, Levetiracetam, Topiramate, Phenytoin
- Bipolar disorder: Lithium carbonate, Quetiapine, Lamotrigine, Olanzapine
- Migraine prevention: Propranolol, Topiramate, Amitriptyline
Pros & Cons (summary):
- Lithium: More monitoring (kidney/thyroid); lower teratogenic risk than valproate
- Lamotrigine: Fewer metabolic side effects; risk of rash (including rare severe rash)
- Levetiracetam: Favourable safety, sometimes mood changes or irritability
- Carbamazepine: Alternative for some seizure types, but may worsen others
- Quetiapine/Olanzapine: Useful for bipolar, but higher risk of weight gain
- Topiramate: Used for migraine/epilepsy, but may cause weight loss and cognitive side effects
13. Legal, Registration, and Reimbursement Status in Australia
- TGA (Therapeutic Goods Administration): Divalproex/valproate is registered prescription medicine, available under Section 85 of the PBS for eligible conditions.
- Prescription: Required by authorised prescriber (GP, neurologist, psychiatrist).
- PBS Subsidy: Yes, with approved indication (epilepsy, bipolar disorder, migraine prevention).
- Schedule: S4 (prescription only); strict controls for supply and repeat prescriptions.
- Specialist review: Required for women/girls of childbearing age due to high birth defect risk. Pregnancy Prevention Programme in place—yearly written review required.
14. Latest Research and Clinical Guidance (2022–2025)
- Recent Royal Australian and New Zealand College of Psychiatrists (RANZCP) and Epilepsy Society Guideline updates recommend valproate only when benefits outweigh risks, especially in young women (RANZCP, 2023).
- Pooled data (Lancet Neurology, 2022–2024): Valproate remains highly effective for generalised epilepsy and rapid mood stabilisation but underscores strict contraceptive measures due to teratogenic risk.
- Therapeutic Drug Monitoring Guidance (TDM, Australia, 2023): Routine plasma level checks are advised for children, elderly, pregnant women, and those with fluctuating clinical control.
- Migraine Prophylaxis: Emerging evidence supports use at lower doses to minimise side effects (BMJ, 2024).
- Development of safer alternatives for women of reproductive age is ongoing (Australian Prescriber, 2023).
15. Availability and Delivery in Australia
| Pack Size | Form/Brand (Examples) | PBS Price/Indicative Price* | Capital City Delivery (Business Days) |
|---|---|---|---|
| 100 tablets | Epilim 200 mg tablets | $6.60 (PBS co-payment eligible adults); $30–$50 (private) | Sydney: 1-2 Melbourne: 1-2 Brisbane: 2-3 Perth: 3-5 Adelaide: 2-3 Hobart: 3-4 |
| 112 tablets | Valproate Sandoz 500 mg modified release | $6.60 (PBS); $45–$70 (private) | Sydney: 1-2 Melbourne: 1-2 Brisbane: 2-3 Perth: 3-5 |
| 300 mL bottle | Epilim Syrup 200 mg/5 mL | $6.60 (PBS); $30–$50 (private) | Sydney: 1-2 Melbourne: 1-2 |
*Actual price and delivery may vary by pharmacy and location. Speak to your pharmacist for specific advice and stock status.
16. Frequently Asked Questions (FAQ)
1. Can I take Depakote/divalproex during pregnancy?
Divalproex is not recommended during pregnancy because of a high risk of birth defects and developmental problems. Alternative treatments are usually preferred. If you may become pregnant, use effective contraception and consult your doctor urgently if you plan to or think you might be pregnant.
2. What should I do if I miss a dose?
Take the missed dose as soon as you remember, unless it is nearly time for your next dose. If so, skip the missed dose — do not double up. Keep doses as regular as possible for the best results.
3. Can I drink alcohol while taking Depakote/divalproex?
It is best to avoid or limit alcohol while on this medicine, as alcohol can increase drowsiness and liver risk, and may interact with seizure control. If you drink, discuss safe limits with your doctor or pharmacist.
4. Is Depakote the same as Australian brands like Epilim?
Depakote contains the same active ingredient as many Australian brands (divalproex or valproate). Your pharmacist can advise if switching brands is suitable for you and whether the formulations are equivalent.
5. Are routine blood tests necessary?
Yes. Liver function, blood counts, and sometimes plasma valproate levels should be monitored regularly as advised by your doctor, especially after starting, changing dose, or adding other medicines.
For further information, contact your treating doctor or accredited Australia pharmacy. This information is not a substitute for medical advice. Always follow the guidance of your Australian healthcare team.
